On January 13, 2014, Principal Investigator Charles Grob, M.D., received from the U.S. Drug Enforcement Administration the Schedule I pharmacy license for our new study of MDMA-assisted therapy for social …
On December 13, 2013, the U.S. Drug Enforcement Administration inspected the pharmacy where the MDMA will be stored for our upcoming study of MDMA-assisted therapy for social anxiety in autistic adults. …
On September 30, the Research Advisory Panel of California (RAPC) approved the amended protocol for our upcoming study of MDMA-assisted therapy for social anxiety in autistic adults. The RAPC review is …
On June 4, 2013, we submitted to the FDA the amended protocol for our planned study of MDMA-assisted therapy for social anxiety in autistic adults, along with a detailed response to the April 30 Advice …
On April 30, 2013, the U.S. Food and Drug Administration approved the protocol design for our pioneering study of MDMA-assisted therapy for social anxiety in autistic adults. The Advice Letter (pdf) from …
We are welcoming proposals for a MAPS-sponsored pilot study of MDMA for Asperger’s syndrome and Autism Spectrum Disorders from interested researchers until December 16. A number of people with high-functioning …
